Cardiac implantable electronic device surgery with interruption of warfarin forgoing post-operative bridging therapy in patients with moderate or high thromboembolic risks.

Autor: Ng, Andrew Kei-Yan1 (AUTHOR) drandrewkyng@gmail.com, Ng, Pauline Yeung2,3 (AUTHOR), Tam, Eva Wai-Ying1 (AUTHOR), Siu, Chung-Wah4 (AUTHOR), Fan, Katherine1 (AUTHOR)
Zdroj: Thrombosis Journal. 4/29/2021, Vol. 19 Issue 1, p1-8. 8p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje